Villemonteix, Thomas http://orcid.org/0000-0002-1662-0672
Rogers, Jack C.
Courbet, Ophélie
Gonzalez-Madruga, Karen
Kohls, Gregor
Raschle, Nora M.
Stadler, Christina
Konrad, Kerstin
Freitag, Christine M.
Fairchild, Graeme
De Brito, Stéphane A.
Funding for this research was provided by:
Seventh Framework Programme (FP7/2007-2013)
Article History
Accepted: 5 July 2021
First Online: 23 August 2021
Declarations
: The FemNAT-CD study ((4); ExternalRef removed) was conducted in accordance with legal regulations outlined by the European Union, national legislation and the Declaration of Helsinki. Study protocols were approved by local ethical committees at each site prior to data collection: RWTH Aachen University Hospital (EK027/14) for the Aachen site, the Ethics Commission Northwest and Central Switzerland (EKNZ: 336/13) for the Basel site, and the University Ethics Committee (ERGO Number: 18970) and the National Health Service Research Ethics Committee (NRES Committee West Midlands, Edgbaston; REC Reference 13/WM/0483) for the two UK sites (Birmingham and Southampton.
: Dr. Raschle has received grant support as a Jacobs Foundation Early Career Fellow 2017-2019 (grant no. 2016 1217 13). Prof. Stadler has received royalties for a book on aggression. Prof. Konrad has received speaker fees from Shire Pharmaceuticals and Medice. Prof. Freitag has received royalties for books on Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. She has served as consultant to Desitin and Roche. Dr. De Brito has received speaker fees from the Child Mental Health Centre and the Centre for Integrated Molecular Brain Imaging. Drs. Gonzalez-Madruga, Rogers, Kohls, Fairchild, Villemonteix and Ms. Courbet report no biomedical financial interests or potential conflicts of interest.